Name: Fulcrum Therapeutics, Inc. (FULC) Balance Sheet
Creator: FinSpry

Fulcrum Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Fulcrum Therapeutics, Inc. (FULC) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019
Current Assets
Cash and Cash Equivalents	58.21	25.56	35.10	35.41	57.05	96.71
Short-Term Investments	182.81	210.66	167.82	182.75	55.86	0.00
Cash & Short-Term Investments	241.02	236.22	202.92	218.16	112.91	96.71
Accounts Receivable	3.34	2.25	1.08	4.11	2.71	0.00
Inventory	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	5.56	3.73	3.52	3.73	3.82	0.28
Total Current Assets	249.92	242.20	207.52	226.00	119.51	100.08
Non-Current Assets
Property, Plant & Equipment (Net)	9.58	12.39	15.97	7.37	8.40	9.21
Other Non-Current Assets	1.21	3.10	3.20	1.63	1.67	1.15
Total Non-Current Assets	10.80	15.50	19.17	9.00	10.07	10.36
Total Assets	260.72	257.69	226.69	235.00	129.58	110.44
Current Liabilities
Accounts Payable	1.16	2.76	3.64	4.79	4.08	2.66
Short-Term Debt	2.19	0.00	0.00	0.00	0.00	0.00
Accrued Liabilities	7.23	8.33	9.45	9.16	7.21	0.00
Deferred Revenue	0.00	0.00	0.93	4.71	14.91	0.00
Other Current Liabilities	0.46	0.40	0.11	0.54	0.51	5.50
Total Current Liabilities	11.04	13.68	16.73	19.20	26.73	12.14
Non-Current Liabilities
Long-Term Debt	6.44	8.63	10.82	0.00	0.00	0.00
Other Non-Current Liabilities	0.20	0.20	0.20	4.26	4.70	0.06
Total Non-Current Liabilities	6.64	8.83	11.02	4.26	7.67	11.15
Total Liabilities	17.68	22.50	27.74	23.46	34.40	23.29
Stockholders' Equity
Common Stock	0.05	0.06	0.05	0.04	0.03	0.00
Retained Earnings	-519.40	-509.67	-412.34	-302.47	-221.62	-150.80
Accumulated Other Comprehensive Income	0.13	-0.14	-0.80	-0.40	0.00	0.00
Additional Paid-in Capital	762.25	744.94	612.03	514.36	316.78	237.93
Shares Outstanding	53.97	61.92	52.10	40.63	0.00	0.00
Total Stockholders' Equity	243.03	235.19	198.94	211.54	95.18	87.15
Total Liabilities & Equity	260.72	257.69	226.69	235.00	129.58	110.44